# Hydrogel Patch for the Treatment of Eczema

> **NCT00924508** · NA · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 23 (actual)

## Conditions studied

- Eczema

## Interventions

- **DEVICE:** hydrogel patch
- **DRUG:** Triamcinolone (TAC) 0.1% cream

## Key facts

- **NCT ID:** NCT00924508
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-07
- **Primary completion:** 2011-09
- **Final completion:** 2012-07
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Loss of Funding
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00924508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00924508, "Hydrogel Patch for the Treatment of Eczema". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00924508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*